General Western Blot Reagents
Genscript Corporation WB-MASTER Protein Standard
WB-MASTER Protein Standard is designed for convenient protein identification in western blot. This standard consists of seven recombinant proteins with molecular weight of 20 kDa, 30 kDa, 40 kDa, 50 kDa, 60 kDa, 80 kDa and 120 kDa. Each of the proteins contains an IgG binding site that is able to bind to primary or secondary antibodies derived from a wide range of host species. The standard thus enables direct visualization of both the protein marker and users' samples on the same western blot membrane without any additional reagents.
Abcam Human Histone H3 (unmodified) peptide, 500UG
Human Histone H3 (unmodified) peptide is a Synthetic blocking peptide. >90% purity and suitable for Dot, BL.
Protein/ Peptide/ Enzyme Synonyms: H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, H3C1, H3FC, HIST1H3C, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Acetylglucosamine BSA Glycoconjugate, 50UG
N-Acetylglucosamine BSA Glycoconjugate is a Cow Full Length protein, expressed in Native, with >98% purity and suitable for SDS-PAGE, WB, ELISA.
Protein/ Peptide/ Enzyme Synonyms: Albumin, BSA, ALB
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Misoprostol, Cytoprotective PGE2 analog, 1MG
MW 382.54 g/mol, Purity >98%. Cytoprotective PGE₂ analog with activity mediated by EP₂, EP₃, and EP₄ receptors (Ki values are 250, 67 and 67 nM, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Sulprostone, EP1/ EP3 receptor agonist, 5MG
MW 465.65 g/mol, Purity >98%. Selective EP₁/ EP₃ receptor agonist (Ki values are 21 and 0.6 nM, respectively). PGE₂ analog.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Prostratin, PKC activator, 500UG
MW 390.48 g/mol. PKC activator; reactivates HIV-1 latency (IC₅₀ = ~0.5 μM) by PKC dependent NF-κB activation. Downregulates expression of HIV-1 receptor CD4 and its co-receptors CXCR4 and CCR5 in vitro. Non-tumor promoting.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Honokiol, anti-inflammatory and chemotherapeutic agent, 10MG
MW 266.34 g/mol, Purity >98%. Potent scavenger of reactive oxygen species with antiangiogenic, antitumor and anti-inflammatory properties. Mechanisms of action include inhibition of ras signalling and activation of the mitochondrial transistion pore via cyclophilin D induction. Inhibits NF-κB signaling, upstream of VEGF. Blood-brain barrier permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Salmeterol x inafoate, beta2 adrenoceptor agonist, 10MG
MW 603.7 Da, Purity >96%. Selective, long acting β2 adrenoceptor agonist. Inhibits release of histamine, leukotrienes, prostaglandin D2 and GM-CSF in concentration-dependent manner. Active *in vitro* and *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ICI 118551 hydrochloride, beta2 adrenoceptor antagonist, 50MG
MW 313.9 Da, Purity >99%. Highly selective β2 adrenoceptor antagonist (Ki values are 1.2, 120 and 257 nM at β2, β1 and β3 receptors, respectively). Blood-brain barrier permeable. Decreases vascular tone *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Honokiol, anti-inflammatory and chemotherapeutic agent, 25MG
MW 266.34 g/mol, Purity >98%. Potent scavenger of reactive oxygen species with antiangiogenic, antitumor and anti-inflammatory properties. Mechanisms of action include inhibition of ras signalling and activation of the mitochondrial transistion pore via cyclophilin D induction. Inhibits NF-κB signaling, upstream of VEGF. Blood-brain barrier permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Olanzapine, 5-HT, dopamine, histamine and muscarinic antagonist, 50MG
MW 312.43 g/mol, Purity >99%. 5-HT and D₂ antagonist (Ki values are 4 (5-HT₂A), 11 (5-HT₂C) and 57 (5-HT₃), 31 (D₁), 11 (D₂) and 27 nM (D₄)). Additionally, displays activity at: M₁, M₂, M₃, M₄, H₁, α₁ and α₂ receptors (Ki are 1.9 at (M₁), 18 (M₂), 25 (M₃), 13 (M₄), 19 (α₁) and 7 nM (α₂)). Atypical antipsychotic. Displays anxiolytic activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Olanzapine, 5-HT, dopamine, histamine and muscarinic antagonist, 10MG
MW 312.43 g/mol, Purity >99%. 5-HT and D₂ antagonist (Ki values are 4 (5-HT₂A), 11 (5-HT₂C) and 57 (5-HT₃), 31 (D₁), 11 (D₂) and 27 nM (D₄)). Additionally, displays activity at: M₁, M₂, M₃, M₄, H₁, α₁ and α₂ receptors (Ki are 1.9 at (M₁), 18 (M₂), 25 (M₃), 13 (M₄), 19 (α₁) and 7 nM (α₂)). Atypical antipsychotic. Displays anxiolytic activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tamo x ifen citrate, Estrogen receptor antagonist and partial agonist, 1G
MW 563.65 g/mol, Purity >99%. Competitive estrogen receptor antagonist and partial agonist. Inhibits estrogen dependent gene transcription and tumor growth. Additionally decreases cardiac infarction and inhibits Kir2.1, Kir2.2 and Kir2.3 potassium channels (IC₅₀ values are 0.93, 0.87 and 0.31 μM, respectively).
The product is subject to the following: Abcam Restricted Use Statement